{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:06:42Z","timestamp":1770836802906,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,4]]},"DOI":"10.7759\/cureus.68626","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T11:34:02Z","timestamp":1725449642000},"source":"Crossref","is-referenced-by-count":1,"title":["Olanzapine-Induced Acute Pulmonary Embolism"],"prefix":"10.7759","author":[{"given":"Jihane","family":"Moussaoui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikram","family":"Saadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Barrimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/2049-6958-8-75","article-title":"Diagnosis and treatment of pulmonary embolism: A multidisciplinary approach","volume":"8","author":"Lavorini F","year":"2013","unstructured":"Lavorini F, Di Bello V, De Rimini ML, et al.. Diagnosis and treatment of pulmonary embolism: A multidisciplinary approach. Multidiscip Respir Med. 2013, 8:75. 10.1186\/2049-6958-8-75","journal-title":"Multidiscip Respir Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.150124","article-title":"Pulmonary thromboembolism associated with olanzapine treatment","volume":"128","author":"Wang Q","year":"2015","unstructured":"Wang Q, Guan L, Li RM, Zhao B. Pulmonary thromboembolism associated with olanzapine treatment. Chin Med J (Engl). 2015, 128:419-20. 10.4103\/0366-6999.150124","journal-title":"Chin Med J (Engl)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200216110-00005","article-title":"Antipsychotic-induced venous thromboembolism: A review of the evidence","volume":"16","author":"H\u00e4gg S","year":"2002","unstructured":"H\u00e4gg S, Spigset O. Antipsychotic-induced venous thromboembolism: A review of the evidence. CNS Drugs. 2002, 16:765-76. 10.2165\/00023210-200216110-00005","journal-title":"CNS Drugs"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0656","article-title":"Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Geerts WH","year":"2008","unstructured":"Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008, 133:381S-453S. 10.1378\/chest.08-0656","journal-title":"Chest"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides SV","year":"2020","unstructured":"Konstantinides SV, Meyer G, Becattini C, et al.. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020, 41:543-603. 10.1093\/eurheartj\/ehz405","journal-title":"Eur Heart J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2018.02.030","article-title":"Antipsychotic drugs and the risk of recurrent venous thromboembolism: A prospective cohort study","volume":"52","author":"Mollard LM","year":"2018","unstructured":"Mollard LM, Le Mao R, Tromeur C, et al.. Antipsychotic drugs and the risk of recurrent venous thromboembolism: A prospective cohort study. Eur J Intern Med. 2018, 52:22-7. 10.1016\/j.ejim.2018.02.030","journal-title":"Eur J Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.53505","article-title":"Integrating cardiac biomarkers and electrocardiogram in pulmonary embolism prognosis","volume":"16","author":"Borkowski P","year":"2024","unstructured":"Borkowski P, Singh N, Borkowska N, Mangeshkar S, Nazarenko N. Integrating cardiac biomarkers and electrocardiogram in pulmonary embolism prognosis. Cureus. 2024, 16:e53505. 10.7759\/cureus.53505","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2017.07.026","article-title":"Acute mass\u0131ve pulmonary embolism assoc\u0131ated w\u0131th olanzap\u0131ne","volume":"35","author":"Keles E","year":"2017","unstructured":"Keles E, Ulasli SS, Basaran NC, Babaoglu E, Koksal D. Acute mass\u0131ve pulmonary embolism assoc\u0131ated w\u0131th olanzap\u0131ne. Am J Emerg Med. 2017, 35:1582.e5-7. 10.1016\/j.ajem.2017.07.026","journal-title":"Am J Emerg Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2012.10.002","article-title":"Incidence of venous thromboembolism in psychiatric units","volume":"130","author":"Delluc A","year":"2012","unstructured":"Delluc A, Montavon S, Canceil O, et al.. Incidence of venous thromboembolism in psychiatric units. Thromb Res. 2012, 130:e283-8. 10.1016\/j.thromres.2012.10.002","journal-title":"Thromb Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/718950","article-title":"Pulmonary embolism related to amisulpride treatment: A case report","volume":"2013","author":"Skokou M","year":"2013","unstructured":"Skokou M, Gourzis P. Pulmonary embolism related to amisulpride treatment: A case report. Case Rep Psychiatry. 2013, 2013:718950. 10.1155\/2013\/718950","journal-title":"Case Rep Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2017.07.092","article-title":"Incidence and risk factors of venous thromboembolism: Peculiarities in psychiatric institutions","volume":"248","author":"Gaertner S","year":"2017","unstructured":"Gaertner S, Pi\u00e9mont A, Faller A, et al.. Incidence and risk factors of venous thromboembolism: Peculiarities in psychiatric institutions. Int J Cardiol. 2017, 248:336-41. 10.1016\/j.ijcard.2017.07.092","journal-title":"Int J Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2210","article-title":"Antipsychotic drugs and risk of pulmonary embolism","volume":"21","author":"Allenet B","year":"2012","unstructured":"Allenet B, Schmidlin S, Genty C, Bosson JL. Antipsychotic drugs and risk of pulmonary embolism. Pharmacoepidemiol Drug Saf. 2012, 21:42-8. 10.1002\/pds.2210","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/pds.841","article-title":"Psychotropic drugs and fatal pulmonary embolism","volume":"12","author":"Parkin L","year":"2003","unstructured":"Parkin L, Skegg DC, Herbison GP, Paul C. Psychotropic drugs and fatal pulmonary embolism. Pharmacoepidemiol Drug Saf. 2003, 12:647-52. 10.1002\/pds.841","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-11-2","article-title":"Markers of thrombogenesis are activated in unmedicated patients with acute psychosis: A matched case control study","volume":"11","author":"Masopust J","year":"2011","unstructured":"Masopust J, Mal\u00fd R, Andr\u00fds C, Vali\u0161 M, Ba\u017eant J, Hos\u00e1k L. Markers of thrombogenesis are activated in unmedicated patients with acute psychosis: A matched case control study. BMC Psychiatry. 2011, 11:2. 10.1186\/1471-244X-11-2","journal-title":"BMC Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2019.10.003","article-title":"Increased risk for venous thromboembolism among patients with concurrent depressive, bipolar, and schizophrenic disorders","volume":"61","author":"Lin CE","year":"2019","unstructured":"Lin CE, Chung CH, Chen LF, Chien WC. Increased risk for venous thromboembolism among patients with concurrent depressive, bipolar, and schizophrenic disorders. Gen Hosp Psychiatry. 2019, 61:34-40. 10.1016\/j.genhosppsych.2019.10.003","journal-title":"Gen Hosp Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2014.12.042","article-title":"Global hypercoagulability in patients with schizophrenia receiving long-term antipsychotic therapy","volume":"162","author":"Chow V","year":"2015","unstructured":"Chow V, Reddel C, Pennings G, et al.. Global hypercoagulability in patients with schizophrenia receiving long-term antipsychotic therapy. Schizophr Res. 2015, 162:175-82. 10.1016\/j.schres.2014.12.042","journal-title":"Schizophr Res"},{"key":"ref17","article-title":"Thrombotic complications of treatment with antipsychotic drugs","volume":"104","author":"Shulman M","year":"2013","unstructured":"Shulman M, Jennifer Njoku I, Manu P. Thrombotic complications of treatment with antipsychotic drugs. Minerva Med. 2013, 104:175-84.","journal-title":"Minerva Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2007.07.074","article-title":"Pulmonary thromboembolism associated with olanzapine and risperidone","volume":"35","author":"Borras L","year":"2008","unstructured":"Borras L, Eytan A, de Timary P, Constant EL, Huguelet P, Hermans C. Pulmonary thromboembolism associated with olanzapine and risperidone. J Emerg Med. 2008, 35:159-61. 10.1016\/j.jemermed.2007.07.074","journal-title":"J Emerg Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjopharm.2011.03.004","article-title":"Risk of serious cardiac events in older adults using antipsychotic agents","volume":"9","author":"Mehta S","year":"2011","unstructured":"Mehta S, Chen H, Johnson M, Aparasu RR. Risk of serious cardiac events in older adults using antipsychotic agents. Am J Geriatr Pharmacother. 2011, 9:120-32. 10.1016\/j.amjopharm.2011.03.004","journal-title":"Am J Geriatr Pharmacother"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2013.04.001","article-title":"Incidence of deep vein thrombosis in restrained psychiatric patients","volume":"55","author":"Ishida T","year":"2014","unstructured":"Ishida T, Katagiri T, Uchida H, Takeuchi H, Sakurai H, Watanabe K, Mimura M. Incidence of deep vein thrombosis in restrained psychiatric patients. Psychosomatics. 2014, 55:69-75. 10.1016\/j.psym.2013.04.001","journal-title":"Psychosomatics"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2017.12.003","article-title":"The impact of antipsychotics as a risk factor for thromboembolism","volume":"70","author":"Og\u0142odek EA","year":"2018","unstructured":"Og\u0142odek EA, Just MJ, Grzesi\u0144ska AD, Araszkiewicz A, Szromek AR. The impact of antipsychotics as a risk factor for thromboembolism. Pharmacol Rep. 2018, 70:533-9. 10.1016\/j.pharep.2017.12.003","journal-title":"Pharmacol Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/257288-olanzapine-induced-acute-pulmonary-embolism","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T11:34:06Z","timestamp":1725449646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/257288-olanzapine-induced-acute-pulmonary-embolism"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,4]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.68626","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,4]]}}}